Developing a Safe TB Specimen Pooling Protocol
Pooling respiratory specimens can help tuberculosis laboratories stretch limited supplies, reduce hands-on testing time, and preserve capacity during periods of high demand. The approach involves combining aliquots from several individual specimens and testing the combined material as one unit. If a pool produces a positive or otherwise actionable result, the original specimens are tested separately.
This strategy is not a substitute for a reliable diagnostic system. Its value depends on the test platform, disease prevalence, specimen quality, laboratory capacity, and the consequences of delayed or missed detection. A written protocol turns those conditions into consistent decisions that staff can apply across shifts and facilities.
In low-resource settings, the protocol should be practical enough for routine use while protecting patients from avoidable delays. It should define which specimens may be pooled, how pools are prepared, what happens after each result, and how the process is monitored through the laboratory quality management system.
Define The Purpose And Scope
Start by identifying the operational problem pooling is intended to solve. The objective may be to conserve molecular test cartridges, manage a temporary backlog, maintain testing during supply interruptions, or increase access to screening in a high-volume service. The protocol should state whether pooling is for diagnostic testing, surveillance, contact investigations, outbreak response, or another defined purpose.
The scope must identify the specimen type, patient group, test method, facility, and staff authorized to perform the procedure. Sputum specimens are often the primary concern in TB testing, but local procedures may involve other respiratory materials. A protocol should never assume that evidence from one specimen type or assay automatically applies to another.
Specify situations in which pooling is prohibited or requires senior approval. Examples can include patients with a strong clinical suspicion of TB, people at high risk of severe disease, children or individuals unable to produce adequate specimens, urgent drug-resistance investigations, and specimens collected for follow-up of a previously positive result. Individual testing is generally preferable when a delayed result could change immediate clinical management.
Set Eligibility And Pool Size Rules
Eligibility criteria should be simple, observable, and documented before specimens enter the pooling workflow. Each specimen needs a unique identifier, an adequate volume, an acceptable container, and a collection date within the permitted testing interval. Leaking, unlabeled, visibly contaminated, or insufficient specimens should be rejected or handled under the laboratory’s existing nonconforming-sample procedure.
Pool size must be determined using local evidence rather than convenience. Larger pools may save more reagents, but dilution can reduce the likelihood of detecting low concentrations of Mycobacterium tuberculosis or resistance markers. A smaller pool may be appropriate when prevalence is high, specimens are often paucibacillary, or the assay has limited analytical sensitivity.
The protocol should include a decision rule for changing pool size. Relevant data include the positivity rate, invalid or error rate, number of pools requiring resolution, turnaround time, and reagent consumption per reportable result. A laboratory may begin with a conservative pool size, assess performance over a defined period, and revise it only through documented authorization and verification.
Design The Bench Workflow
Pooling should take place in a designated area using the same infection prevention controls required for individual specimen processing. Staff need clear instructions for opening containers, mixing or aliquoting material, disinfecting work surfaces, managing aerosols, and disposing of waste. If a biosafety cabinet is required by local risk assessment or equipment instructions, its availability and certification must be addressed before implementation.
A practical workflow separates identification, preparation, testing, and result interpretation. Two staff members, or a staff member and an electronic verification step, should check the identities of all specimens entering a pool. The pool must receive its own identifier linked to every contributing specimen. Labels should remain legible after contact with disinfectant and should never replace the original patient identifiers in the laboratory information system.
The procedure should explain how equal aliquots are produced, how specimens are mixed, and how remaining material is preserved for reflex testing. Staff should avoid repeated opening and transferring of containers. If a pool is positive, invalid, or produces an error, the protocol must specify whether all component specimens are tested individually, whether a repeat pool is allowed, and how the event is prioritized.
Verify Performance Before Routine Use
Before adopting pooling, the laboratory should conduct a documented verification under local operating conditions. The exercise can use characterized residual specimens, external quality assessment material where appropriate, or a carefully designed comparison with individually tested specimens. The aim is to confirm that the proposed pool size and preparation method work with the actual assay, consumables, staff, and equipment available.
Performance review should examine agreement between pooled and individual testing, detection of low-positive material, invalid results, contamination events, and time to final reporting. If the assay provides semiquantitative information, the laboratory should assess whether pooling affects interpretation or creates uncertainty about reporting categories. A manufacturer’s instructions and national TB guidance should be checked for restrictions on specimen manipulation.
Quality indicators make the process visible after implementation. Useful measures include the percentage of eligible specimens pooled, proportion of positive pools, number of individual reflex tests, invalid and error rates, average turnaround time, rejected specimens, transcription errors, and reagent use per completed patient result. Trends should be reviewed at regular quality meetings, with corrective actions recorded when targets are missed.
| Protocol Element | Practical Low-Resource Approach | Key Risk To Control |
|---|---|---|
| Eligibility | Use clear criteria for volume, labeling, specimen type, and clinical priority | Including unsuitable or urgent specimens |
| Pool size | Begin conservatively and revise using local verification data | Dilution-related false-negative results |
| Identification | Assign a unique pool code linked to every original specimen | Loss of traceability |
| Preparation | Use standardized aliquots, calibrated tools, and controlled handling | Unequal composition or contamination |
| Positive result | Test each contributing specimen individually without avoidable delay | Delayed diagnosis |
| Invalid or error result | Follow a predefined repeat and escalation pathway | Unresolved patient results |
| Monitoring | Review positivity, invalid rates, turnaround time, and incidents | Continuing an unsafe or inefficient process |
Integrate Documentation And Biosafety
The protocol should be controlled as a quality document. It needs a title, identification code, version, effective date, author, reviewer, approver, and review date. Changes to pool size, assay type, specimen eligibility, or result interpretation require documented review rather than informal bench-level adjustments.
A step-by-step worksheet can reduce errors when the laboratory lacks an integrated information system. It should record the pool identifier, contributing specimen identifiers, aliquot volumes, operator, date and time, assay run, result, reflex testing decisions, and final patient-level reports. Any discrepancy must be corrected in a way that preserves the original entry and creates an auditable record.
Training should combine explanation, demonstration, supervised practice, and competency assessment. Staff need to understand why pooling is being used, when not to use it, and how a pooled result affects the next action. The user instructions for the GLI Quality Tool can help laboratories connect this procedure with broader requirements for personnel, equipment, documents, assessment, and continual improvement.
Biosafety planning should cover spills, leaks, centrifugation if used, aerosol-generating steps, waste treatment, exposure response, and availability of personal protective equipment. Pooling can increase the number of specimen manipulations, so reagent savings should never be pursued by removing controls that protect staff or prevent cross-contamination.
Interpret Results And Protect Patients
The result algorithm must be written in terms that laboratory staff and clinicians can apply consistently. A negative pool may allow reporting only when the laboratory has verified that pooling is suitable for the relevant population and assay. A positive pool should trigger prompt individual testing of every contributing specimen, with priority given to patients whose clinical condition or contact status warrants rapid action.
Invalid or error results require their own pathway. The laboratory should distinguish an instrument problem, an internal control failure, a specimen issue, and a suspected contamination event where possible. Repeating the same pooled material may be appropriate in some circumstances, but it should not become an automatic substitute for individual resolution when the result remains uncertain.
Reports should make clear whether the result applies to a pool or to an individual patient. Patient reports should not be issued as positive or negative solely on the basis of an unresolved pool. The protocol should define who communicates delays, how clinicians are notified of actionable findings, and how results are amended if a later investigation changes the interpretation.
Recommendations For Sustainable Implementation
A phased rollout is usually safer than immediate use across all samples. Begin with a limited service area or defined specimen group, collect performance data, and hold a formal review before expanding. Include laboratory staff, clinicians, specimen-collection teams, infection prevention personnel, and program managers in that review so operational effects are not considered in isolation.
Resource limitations should be addressed explicitly. If the laboratory has no reliable system for tracking component specimens, pooling may create more risk than benefit. If equipment downtime, reagent interruptions, or staff shortages are frequent, the protocol should include contingency arrangements for individual testing and referral to another qualified site.
Practical safeguards include:
- Verify the pooling method, assay, and proposed pool size before routine patient testing.
- Exclude urgent, high-risk, poorly labeled, leaking, and inadequate specimens unless an authorized exception exists.
- Link every pool and reflex test to the original patient identifier through controlled records.
- Use a predefined pathway for positive, invalid, error, and contaminated results.
- Review quality indicators and patient impact at scheduled quality management meetings.
A controlled protocol should remain adaptable without becoming ambiguous. Local data may justify a different pool size or eligibility rule over time, but every change should be supported by evidence, approved through document control, and followed by staff retraining when necessary.
Laboratories considering pooling should assemble the protocol, verification plan, worksheets, training materials, and monitoring indicators before the first patient specimen is combined. When the process is anchored in traceability, biosafety, and timely resolution of positive pools, it can extend testing capacity while preserving the quality principles essential to TB diagnosis.